Kotaro Sugimoto

Associate Professor

Fukushima Medical University

Japan

Research Interests

Explore related searches

Professors in Japan Professors in Cancer Biology Cancer Biology professors in Japan

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Kotaro Sugimoto is an Associate Professor at Fukushima Medical University, Japan. His research areas include cancer biology, with a focus on the role of tight junctions and signaling pathways in cancer progression, as well as the identification of prognostic biomarkers for various cancers. Recent publications highlight his work on the relationship between adhesion signaling and cancer metabolism, in addition to clinical findings related to specific syndromes.

Articles (12)

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (1)

Hideki Chiba

Fukushima Medical University

JAPAN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Kotaro Sugimoto

Research Interests

Explore related searches

Contact this professor

About

Articles (12)

A Novel Tight Junction–Nuclear Receptor Signaling Pathway Regulating Cancer Progression

Comparison of clinical findings and subjective symptoms in a case of multiple evanescent white dot syndrome (MEWDS): A case report from a patient's perspective

The Src-Family Kinases SRC and BLK Contribute to the CLDN6-Adhesion Signaling

Aberrant phosphorylation of human LRH1 at serine 510 is predictable of hepatocellular carcinoma recurrence.

SPON1 is an independent prognostic biomarker for ovarian cancer.

SPON1 is an independent prognostic biomarker for ovarian cancer

Claudin-4-adhesion signaling drives breast cancer metabolism and progression via liver X receptor β.

Claudin-4-adhesion signaling drives breast cancer metabolism and progression via liver X receptor beta

Claudin‑9 is a novel prognostic biomarker for endometrial cancer.

Claudin-9 is a novel prognostic biomarker for endometrial cancer

Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with small cell lung cancer and cytotoxic T-cell-mediated pathology: Case report.

Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with small cell lung cancer and cytotoxic T-cell-mediated pathology: Case report

Collaborators (1)

Hideki Chiba

Make your next move.